Why the study?
A significant bleeding risk remains with NOACs in atrial fibrillation, requiring appropriate management for bleeding or invasive surgery since discontinuation may increase thromboembolic risk.
Provides the 2018 Korean Heart Rhythm Society practical guidelines for managing bleeding and perioperative care in AF patients on NOACs.
Answers are grounded in this paper and cite their sources.
Guides safe NOAC use in Korean AF practice; extends global evidence into localized perioperative recommendations.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2019) conducted a review in Atrial fibrillation requiring anticoagulation. Non-Vitamin K-Antagonist Oral Anticoagulants (NOACs) was evaluated. Non-vitamin K-antagonist oral anticoagulants require specific management strategies for bleeding control and perioperative care, including temporary discontinuation based on bleeding risk and renal function.
Synapse has enriched 10 related papers. Consider them for comparative context: